Current and future therapy for pulmonary hypertension in patients with right and left heart failure

Expert Review of Cardiovascular Therapy
Khaled AbdelhadyMalek G Massad

Abstract

Pulmonary hypertension (PH) is a devastating condition that without proper management can deteriorate progressively. Elevated pulmonary artery pressure without an identifiable etiology is called IPAH. PH resulting from a specific disease is referred to as secondary PH; left-sided cardiac disease can lead to an increase in pulmonary artery pressure resulting in increased vascular resistance and subsequent structural remodeling. If left-sided failure progresses to right-sided failure with high pulmonary artery pressure, the outcome is ominous. It has been clearly proven that early diagnosis and effective medical therapy can markedly decrease morbidity and mortality. In this review, we discuss the current treatment modalities and their limitations for PH secondary to heart failure. Conventional therapy in patients with pulmonary arterial hypertension as well as recent advances in the medical management of PH in general, are also described. Last, the surgical management of these patients and other promising interventional modalities are reviewed.

References

Jun 1, 1990·Circulation·K M MoserP F Fedullo
Aug 1, 1989·Atherosclerosis·Y HirataF Marumo
Aug 1, 1987·Annals of Internal Medicine·S RichS K Koerner
May 15, 1983·The American Journal of Cardiology·S Rich, W Lam
Feb 19, 1999·Lancet·A Benigni, G Remuzzi
Nov 24, 1999·Thorax·A J Peacock
Jun 14, 2000·Mayo Clinic Proceedings·M J Krowka
Feb 24, 2001·The New England Journal of Medicine·S PrasadM A Gatzoulis
Sep 8, 2001·AIDS·Y O SchumacherW Kreisel
Nov 1, 2001·Respiratory Research·K A FaganD M Rodman
Jan 17, 2002·The New England Journal of Medicine·P F FedulloL J Rubin
Jan 24, 2002·American Journal of Respiratory Cell and Molecular Biology·Lucie H ClappAndrew Tinker
Apr 3, 2002·Annals of Internal Medicine·Hossein Ardeschir GhofraniFriedrich Grimminger
Jul 9, 2002·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Thomas K WaddellShaf H Keshavjee
Aug 2, 2002·The New England Journal of Medicine·Horst OlschewskiUNKNOWN Aerosolized Iloprost Randomized Study Group
Sep 3, 2002·Journal of the American College of Cardiology·Olivier SitbonGérald Simonneau
Sep 18, 2002·Circulation·Vallerie V McLaughlinStuart Rich
Oct 2, 2002·Lancet·Hossein Ardeschir GhofraniFriedrich Grimminger
Nov 2, 2002·Progress in Cardiovascular Diseases·Olivier SitbonGérald Simonneau
May 3, 2003·The Journal of Clinical Investigation·Ventzislav PetkovLutz-Henning Block
May 30, 2003·American Journal of Respiratory and Critical Care Medicine·Elisabeth MarcosSaadia Eddahibi
Jun 25, 2003·Journal of the American College of Cardiology·Robyn J BarstUNKNOWN Beraprost Study Group
Jul 10, 2003·Journal of the American College of Cardiology·Hossein A GhofraniFriedrich Grimminger
Nov 7, 2003·The Annals of Thoracic Surgery·Stuart W JamiesonWilliam R Auger
Nov 25, 2003·American Journal of Respiratory and Critical Care Medicine·Robyn J BarstUNKNOWN STRIDE-1 Study Group
Dec 26, 2003·American Journal of Respiratory and Critical Care Medicine·Marc Humbert, Gérald Simonneau

❮ Previous
Next ❯

Citations

Jan 23, 2020·Ethics & Human Research·Carolyn Riley ChapmanAlison S Bateman-House

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.